Dr. Jan Gheuens serves as deputy director, drugs, for our tuberculosis strategy. He leads the foundation’s team that focuses on the development of new TB drugs.
Previously, he was with Amgen, where he was Vice President, Global Development Operations, and R&D in Japan. Prior to his six years at Amgen, Jan spent 10 years at Johnson & Johnson. In the course of his industry career, he took on different product development, clinical development, and medical affairs roles.
He is an M.D., trained as a neurologist and has a Ph.D. in Neuroimmunology. He served for seven years on the faculty at the University Hospital of Antwerp in his native Belgium before joining the healthcare industry.